Outcomes of Treatment in Ocular Myasthenia Gravis Based on Minimal Manifestation: A Real-World Retrospective Cohort Study
Early prednisolone initiation (within 6 months) and higher pyridostigmine doses were linked to remission, highlighting treatment factors over demographics in OMG outcomes.
Authors
- Parinee Kemchoknatee (ORCID: https://orcid.org/0000-0002-7153-0813)
- Thansit Srisombut (ORCID: https://orcid.org/0000-0002-6284-9590)
- Boonravee Santitamrongvtit
Institutions
- Mahidol University (TH)
- Rajavithi Hospital (TH)
- Ramathibodi Hospital (TH)
- King Mongkut Memorial Hospital (TH)
- Rangsit University (TH)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/opth.s520136
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00